Effect of anti-TNFα treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis

Life Sciences

Volumn 79, Issue 25, 2006, Pages 2364-2369

  Ablin, Jacob N ^a   Boguslavski, Viktoria ^a   Aloush, Valerie ^a   Elkayam, Ori ^a   Paran, Daphna ^a   Caspi, Dan ^a   George, Jacob ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; Anti TNF ; EPC; Rheumatoid arthritis

Indexed keywords

HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; ANGIOPOIETIN RECEPTOR; ANTIRHEUMATIC AGENT; CD31 ANTIGEN; CD34 ANTIGEN; FIBRONECTIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CELL ADHESION; CELL ISOLATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MONONUCLEAR CELL; MORBIDITY; PHENOTYPE; RATING SCALE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STEM CELL; BLOOD; BLOOD CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CLONOGENIC ASSAY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; ANTIGENS, CD34; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD CELL COUNT; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ENDOTHELIUM, VASCULAR; FEMALE; FIBRONECTINS; HUMANS; MALE; MIDDLE AGED; RECEPTOR, TIE-2; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33751095370     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.07.035     Document Type: Article

References (31)

1. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31 3 (1988) 315-324
2. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., and Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 5302 (1997) 964-966
3. Assmus B., Urbich C., Aicher A., Hofmann W.K., Haendeler J., Rossig L., Spyridopoulos I., Zeiher A.M., and Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circulation Research 92 9 (2003) 1049-1055
4. Choi H.K., Hernan M.A., Seeger M., Robins J.M., and Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. The Lancet 359 9313 (2002) 1173-1177
5. Choy E.H., and Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine 344 12 (2001) 907-916
6. George J., Herz I., Goldstein E., Abashidze S., Deutch V., Finkelstein A., Michowitz Y., Miller H., and Keren G. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arteriosclerosis, Thrombosis, and Vascular Biology 23 12 (2003) e57-e60
7. George J., Goldstein E., Abashidze A., Wexler D., Hamed S., Shmilovich H., Deutsch V., Miller H., Keren G., and Roth A. Erythropoietin promotes endothelial progenitor cell proliferative and 3 adhesive properties in a PI 3-kinase-dependent manner. Cardiovascular Research 68 2 (2005) 299-306
8. George J., Shmilovich H., Deutsch V., Pick M., Miller H., Keren G., and Roth A. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Engineering 12 2 (2006) 331-335
9. Gonzalez-Juanatey C., Testa A., Garcia-Castelo A., Garcia-Porrua C., Llorca J., and Gonzalez-Gay M.A. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthritis and Rheumatism 51 3 (2004) 447-450
10. Grisar J., Aletaha D., Steiner C.W., Kapral T., Steiner S., Seidinger D., Weigel G., Schwarzinger I., Wolozcszuk W., Steiner G., and Smolen J.S. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111 2 (2005) 204-211
11. Herbrig K., Haensel S., Oelschlaegel U., Pistrosch F., Foerster S., and Passauer J. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Annals Rheumatic Diseases 65 2 (2005) 157-163
12. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New England Journal of Medicine 348 7 (2003) 593-600
13. Hurlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., Bechir M., Spieker L.E., Neidhart M., Michel B.A., Gay R.E., Luscher T.F., Gay S., and Ruschitzka F. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106 17 (2002) 2184-2187
14. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., Silver M., Ma H., Kearney M., Isner J.M., and Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 5 (2001) 634-637
15. Krishnan E., Lingala V.B., and Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 110 13 (2004) 1774-1779
16. Lipsky P.E., van der Heijde D.M., St Clair E.W., Furst D.E., Breedveld F.C., Kalden J.R., Smolen J.S., Weisman M., Emery P., Feldmann M., Harriman G.R., Maini R.N., and Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. New England Journal of Medicine 343 22 (2000) 1594-1602
17. Liu H., and Pope R.M. The role of apoptosis in rheumatoid arthritis. Current Opinion in Pharmacology 3 3 (2003) 317-322
18. Mulvihill N.T., and Foley J.B. Inflammation in acute coronary syndromes. Heart 87 3 (2002) 201-204
19. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., Onitsuka I., Matsui K., and Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. Journal of Clinical Investigation 105 11 (2000) 1527-1536
20. Peeters H.R., Jongen-Lavrencic M., Bakker C.H., Vreugdenhil G., Breedveld F.C., and Swaak A.J. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures. Rheumatology International 18 5-6 (1999) 201-206
21. Prevoo M.L., van 't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., and van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 38 1 (1995) 44-48
22. Ruger B., Giurea A., Wanivenhaus A.H., Zehetgruber H., Hollemann D., Yanagida G., Groger M., Petzelbauer P., Smolen J.S., Hoecker P., and Fischer M.B. Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Arthritis and Rheumatism 50 7 (2004) 2157-2166
23. Seeger F.H., Haendeler J., Walter D.H., Rochwalsky U., Reinhold J., Urbich C., Rossig L., Corbaz A., Chvatchko Y., Zeiher A.M., and Dimmeler S. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111 9 (2005) 1184-1191
24. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., and Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine 5 4 (1999) 434-438
25. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., Levine J.P., and Gurtner G.C. Human endothelial progenitor cells from type ii diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 22 (2002) 2781-2786
26. Van Doornum S., McColl G., and Wicks I.P. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?. Arthritis and Rheumatism 46 4 (2002) 862-873
27. Vaudo G., Marchesi S., Gerli R., Allegrucci R., Giordano A., Siepi D., Pirro M., Shoenfeld Y., Schillaci G., and Mannarino E. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Annals of the Rheumatic Diseases 63 1 (2004) 31-35
28. Vis M., Nurmohamed M.T., Wolbink G., Voskuyl A.E., de Koning M., van de Stadt R., Twisk J.W., Dijkmans B.A., and Lems W.F. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. Journal of Rheumatology 32 2 (2005) 252-255
29. Werner L., Deutsch V., Barshack I., Miller H., Keren G., and George J. Transfer of endothelial progenitor cells improves myocardial performance in rats with dilated cardiomyopathy induced following experimental myocarditis. Journal of Molecular and Cellular Cardiology 39 4 (2005) 691-697
30. Wolfe F., Mitchell D.M., Sibley J.T., Fries J.F., Bloch D.A., Williams C.A., Spitz P.W., Haga M., Kleinheksel S.M., and Cathey M.A. The mortality of rheumatoid arthritis. Arthritis Rheumatism 37 4 (1994) 481-494
31. Young J.L., Libby P., and Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thrombosis and Haemostasis 88 4 (2002) 554-567